Inhibition of Hedgehog and Androgen receptor signaling pathways produced synergistic suppression of castration-resistant prostate cancer progression

Metastatic prostate cancer (PCa) is initially treated with androgen ablation therapy, which causes regression of androgen-dependent tumors. However, these tumors eventually relapse resulting in recurrent castration-resistant prostate cancer (CRPC). Currently, there is no effective therapy for CRPC a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gowda, Pramod S., Deng, Jianhong D., Mishra, Sweta, Bandyopadhyay, Abhik, Liang, Sitai, Lin, Shu, Mahalingam, Devalingam, Sun, Lu-Zhe
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3834015/
https://ncbi.nlm.nih.gov/pubmed/23989930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-13-0278
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars